NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 132 filers reported holding NOVOCURE LTD in Q1 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $125,000 | -53.5% | 2,100 | -34.2% | 0.04% | -34.0% |
| Q4 2019 | $269,000 | +2.7% | 3,190 | -8.9% | 0.05% | -22.1% |
| Q3 2019 | $262,000 | +65.8% | 3,500 | +40.0% | 0.07% | +47.8% |
| Q2 2019 | $158,000 | -69.4% | 2,500 | -77.2% | 0.05% | -33.3% |
| Q1 2019 | $516,000 | +774.6% | 10,946 | +508.1% | 0.07% | +263.2% |
| Q4 2018 | $59,000 | -69.9% | 1,800 | -71.4% | 0.02% | -57.8% |
| Q2 2018 | $196,000 | +444.4% | 6,300 | +270.6% | 0.04% | +400.0% |
| Q1 2018 | $36,000 | +260.0% | 1,700 | +183.3% | 0.01% | +800.0% |
| Q2 2017 | $10,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |